Evolución de la Capacidad de Salto Como Respuesta a un Entrenamiento Pliométrico en Función del Genotipo de ACTN3

  1. Nadal Serrano, Carlos 1
  2. Diez Vega, Ignacio 1
  3. Molina Martín, Juan José 1
  4. López Martínez, Eduardo 1
  5. Cerdá Bejar, Joaquín 1
  1. 1 Universidad Europea de Madrid-España
Revista:
Kronos: revista universitaria de la actividad física y el deporte

ISSN: 1579-5225

Año de publicación: 2015

Volumen: 14

Número: 2

Tipo: Artículo

DIALNET GOOGLE SCHOLAR lock_openABACUS editor

Otras publicaciones en: Kronos: revista universitaria de la actividad física y el deporte

Resumen

El objetivo del presente estudio fue analizar la respuesta muscular a un entrenamiento pliométrico en función del genotipo de ACTN3, mediante la valoración de la evolución de la capacidad de salto, en un grupo de personas físicamente activas. Se utilizó un diseño experimental con medidas pre-post. Se evaluaron 68 personas jóvenes (21,98 ± 3,20 años) en 4 momentos de tiempo a lo largo de 48 horas. Se analizaron los saltos verticales Squat Jump, Counter Movement Jump y Drop Jump. El análisis de resultados se realizó con un ANOVA mixto de 3x4. La distribución de los genotipos de ACTN3, fue estadísticamente diferente en comparación con la mostrada en estudios que evalúan deportistas de potencia/velocidad, pero no así con los estudios que evalúan a deportistas de resistencia o a no deportistas. En cuanto al análisis del efecto del entrenamiento pliométrico, no se obtuvieron diferencias estadísticamente significativas ni de forma grupal ni de forma segregada en función del genotipo. En conclusión, los genotipos del gen ACTN3 no parecen modificar la altura alcanzada en los saltos tras realizar el entrenamiento pliométrico propuesto en el estudio.

Referencias bibliográficas

  • Ahmetov, I. I., Druzhevskaya, A. M., Astratenkova, I. V., Popov, D. V., Vinogradova, O. L., & Rogozkin, V. A. (2010). The ACTN3 R577X polymorphism in russian endurance athletes. British Journal of Sports Medicine, 44(9), 649-652. doi:10.1136/bjsm.2008.051540 [
  • Alfred, T., Ben‐Shlomo, Y., Cooper, R., Hardy, R., Cooper, C., Deary, I. J., Martin, R. M. (2011). ACTN3 genotype, athletic status, and life course physical capability: Meta‐analysis of the published literature and findings from nine studies. Human Mutation, 32(9), 1008-1018.
  • Bosco, C. (1994). La valoración de la fuerza con el test de bosco. Barcelona: Paidotribo.
  • Bray, M., Hagberg, J., Perusse, L., Rankinen, T., Roth, S., Wolfarth, B., & Bouchard, C. (2009). The human gene map for performance and health-related fitness phenotypes: The 2006-2007 update. Medicine Science in Sports Exercise, 41(1), 35.
  • Cięszczyk, P., Eider, J., Ostanek, M., Arczewska, A., Leońska-Duniec, A., Sawczyn, S., Krupecki, K. (2011). Association of the ACTN3 R577X polymorphism in polish power-orientated athletes. Journal of Human Kinetics, 28, 55-61.
  • Clarkson, P. M., Devaney, J. M., Gordish-Dressman, H., Thompson, P. D., Hubal, M. J., Urso, M., Hoffman, E. P. (2005). ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. Journal of Applied Physiology (Bethesda, Md.: 1985), 99(1), 154-163. doi:01139.2004 [pii]
  • Clarkson, P. M., Hoffman, E. P., Zambraski, E., Gordish-Dressman, H., Kearns, A., Hubal, M., Devaney, J. M. (2005). ACTN3 and MLCK genotype associations with exertional muscle damage. Journal of Applied Physiology (Bethesda, Md.: 1985), 99(2), 564-569. doi:00130.2005 [pii]
  • Druzhevskaya, A. M., Ahmetov, I. I., Astratenkova, I. V., & Rogozkin, V. A. (2008). Association of the ACTN3 R577X polymorphism with power athlete status in russians. European Journal of Applied Physiology, 103(6), 631-634.
  • Erskine, R., Williams, A., Jones, D., Stewart, C., & Degens, H. (2014). The individual and combined influence of ACE and ACTN3 genotypes on muscle phenotypes before and after strength training. Scandinavian Journal of Medicine & Science in Sports, 24(4), 642-648.
  • Eynon, N., Ruiz, J. R., Femia, P., Pushkarev, V. P., Cieszczyk, P., Maciejewska-Karlowska, A., Kulikov, L. M. (2012). The ACTN3 R577X polymorphism across three groups of elite male european athletes. PloS One, 7(8), e43132.
  • Eynon, N., Ruiz, J. R., Oliveira, J., Duarte, J. A., Birk, R., & Lucia, A. (2011). Genes and elite athletes: A roadmap for future research. The Journal of Physiology, 589(13), 3063-3070.
  • Fábrica, G., González-Rodriguez, P., & Loss, D. J. F. (2013). Cambios en el control neuromuscular de seis músculos de miembro inferior durante CMJ máximos realizados con fatiga. Rev.Bras.Ciênc.Esporte, 35(2), 389-407.
  • Garatachea, N., Verde, Z., Santos-Lozano, A., Yvert, T., Rodriguez-Romo, G., Sarasa, F. J., Lucia, A. (2014). ACTN3 R577X polymorphism and explosive leg-muscle power in elite basketball players. International Journal of Sports Physiology and Performance, 9(2), 226-232. doi:10.1123/ijspp.2012-0331 [
  • Hagberg, J. M., Rankinen, T., Loos, R. J., Perusse, L., Roth, S. M., Wolfarth, B., & Bouchard, C. (2011). Advances in exercise, fitness, and performance genomics in 2010. Medicine and Science in Sports and Exercise, 43(5), 743-752. doi:10.1249/MSS.0b013e3182155d21 [
  • Hanson, E., Ludlow, A., Sheaff, A., Park, J., & Roth, S. (2010). ACTN3 genotype does not influence muscle power. International Journal of Sports Medicine, 31(11), 834.
  • Loos, R. J., Hagberg, J. M., Pérusse, L., Roth, S. M., Sarzynski, M. A., Wolfarth, B., & Bouchard, C. (2015). Advances in exercise, fitness, and performance genomics in 2014. Medicine and science in sports and exercise,47(6), 1105-1112.
  • Lucia, A., Gomez-Gallego, F., Santiago, C., Bandres, F., Earnest, C., Rabadan, M., Villa, G. (2006). ACTN3 genotype in professional endurance cyclists. International Journal of Sports Medicine, 27(11), 880-884.
  • Ma, F., Yang, Y., Li, X., Zhou, F., Gao, C., Li, M., & Gao, L. (2013). The association of sport performance with ACE and ACTN3 genetic polymorphisms: a systematic review and meta-analysis. PloS one, 8(1), e54685.
  • MacArthur, D. G., & North, K. N. (2004). A gene for speed? the evolution and function of α‐actinin‐3. Bioessays, 26(7), 786-795.
  • MacArthur, D. G., Seto, J. T., Raftery, J. M., Quinlan, K. G., Huttley, G. A., Hook, J. W., Berman, Y. (2007). Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans. Nature Genetics, 39(10), 1261-1265.
  • Massidda, M., Corrias, L., Ibba, G., Scorcu, M., Vona, G., & Calo, C. M. (2012). Genetic markers and explosive leg-muscle strength in elite italian soccer players. The Journal of Sports Medicine and Physical Fitness, 52(3), 328-334. doi:R40123559 [pii]
  • Massidda, M., Scorcu, M., & Calo, C. M. (2014). New genetic model for predicting phenotype traits in sports. International Journal of Sports Physiology and Performance, 9(3), 554-560. doi:10.1123/ijspp.2012-0339 [
  • McCauley, T., Mastana, S. S., & Folland, J. P. (2010). ACE I/D and ACTN3 R/X polymorphisms and muscle function and muscularity of older caucasian men. European Journal of Applied Physiology, 109(2), 269-277.
  • McCauley, T., Mastana, S. S., Hossack, J., MacDonald, M., & Folland, J. P. (2009). Human angiotensin‐converting enzyme I/D and α‐actinin 3 R577X genotypes and muscle functional and contractile properties. Experimental Physiology, 94(1), 81-89.
  • Mendoça, E. P., Coelho, D. B., Cruz, I. R., Morandi, R. F., Veneroso, C. E., de Azambuja Pussieldi, G., Fernández, José Antonio De Paz. (2012). The ACTN3 genotype in soccer players in response to acute eccentric training. European Journal of Applied Physiology, 112(4), 1495-1503.
  • Mills, M., Yang, N., Weinberger, R., Vander Woude, D. L., Beggs, A. H., Easteal, S., & North, K. (2001). Differential expression of the actin-binding proteins, alpha-actinin-2 and -3, in different species: Implications for the evolution of functional redundancy. Human Molecular Genetics, 10(13), 1335-1346.
  • Niemi, A., & Majamaa, K. (2005). Mitochondrial DNA and ACTN3 genotypes in finnish elite endurance and sprint athletes. European Journal of Human Genetics, 13(8), 965-969.
  • North, K.N., Yang, N., Wattanasirichaigoon, D., Mills, M., Easteal, S. y Beggs, A.H. (1999). A common nonsense mutation results in alpha-actinin-3 deficiency in the general population. Nature Genetics, 21(4), 353-354.
  • Rodacki, A. L., Fowler, N. E., & Bennett, S. J. (2002). Vertical jump coordination: Fatigue effects. Med Sci Sports Exerc, 34(1), 105-116.
  • Rodríguez Romo, G., Yvert, T., Diego, A. d., Santiago Dorrego, C., Díaz de Durana, Alfonso L, Carratalá Deval, V., Lucía Mulas, A. (2013). No association between ACTN3 R577X polymorphism and elite judo athletic status.
  • Rodríguez-Romo, G., Ruiz, J. R., Santiago, C., Fiuza-Luces, C., González-Freire, M., Gómez-Gallego, F., Lucia, A. (2010). Does the ACE I/D polymorphism, alone or in combination with the ACTN3 R577X polymorphism, influence muscle power phenotypes in young, non-athletic adults? European Journal of Applied Physiology, 110(6), 1099-1106.
  • Roth, S. M., Walsh, S., Liu, D., Metter, E. J., Ferrucci, L., & Hurley, B. F. (2008). The ACTN3 R577X nonsense allele is under-represented in elite-level strength athletes. European Journal of Human Genetics, 16(3), 391-394.
  • Ruiz, J. R., Fernández del Valle, M., Verde, Z., Díez‐Vega, I., Santiago, C., Yvert, T., Lucia, A. (2011). ACTN3 R577X polymorphism does not influence explosive leg muscle power in elite volleyball players. Scandinavian Journal of Medicine & Science in Sports, 21(6), e34-e41.
  • Santiago, C., Rodríguez‐Romo, G., Gómez‐Gallego, F., González‐Freire, M., Yvert, T., Verde, Z., Ruiz, J. R. (2010). Is there an association between ACTN3 R577X polymorphism and muscle power phenotypes in young, non‐athletic adults? Scandinavian Journal of Medicine & Science in Sports, 20(5), 771-778.
  • Santiago, C., Ruiz, J., Muniesa, C., González‐Freire, M., Gómez‐Gallego, F., & Lucia, A. (2010). Does the polygenic profile determine the potential for becoming a world‐class athlete? insights from the sport of rowing. Scandinavian Journal of Medicine & Science in Sports, 20(1), e188-e194.
  • Saunders, C., September, A., Xenophontos, S., Cariolou, M., Anastassiades, L., Noakes, T., & Collins, M. (2007). No association of the ACTN3 gene R577X polymorphism with endurance performance in ironman triathlons. Annals of Human Genetics, 71(6), 777-781.
  • Scott, R. A., Irving, R., Irwin, L., Morrison, E., Charlton, V., Austin, K., Pitsiladis, Y. P. (2010). ACTN3 and ACE genotypes in elite jamaican and US sprinters. Medicine and Science in Sports and Exercise, 42(1), 107-112. doi:10.1249/MSS.0b013e3181ae2bc0 [
  • Seto, J. T., Lek, M., Quinlan, K. G., Houweling, P. J., Zheng, X. F., Garton, F., North, K. N. (2011). Deficiency of alpha-actinin-3 is associated with increased susceptibility to contraction-induced damage and skeletal muscle remodeling. Human Molecular Genetics, 20(15), 2914-2927. doi:10.1093/hmg/ddr196 [
  • Smith, D. J., Roberts, D., & Watson, B. (1992). Physical, physiological and performance differences between Canadian national team and universiade volleyball players. Journal of Sports Sciences, 10(2), 131-138.
  • Vincent, B., Windelinckx, A., Nielens, H., Ramaekers, M., Van Leemputte, M., Hespel, P., & Thomis, M. A. (2010). Protective role of alpha-actinin-3 in the response to an acute eccentric exercise bout. Journal of Applied Physiology (Bethesda, Md.: 1985), 109(2), 564-573. doi:10.1152/japplphysiol.01007.2009 [
  • Yang, N., MacArthur, D. G., Gulbin, J. P., Hahn, A. G., Beggs, A. H., Easteal, S., & North, K. (2003). ACTN3 genotype is associated with human elite athletic performance. The American Journal of Human Genetics, 73(3), 627-631.
  • Yang, N., Macarthur, D., Wolde, B., Onywera, V. O., Boit, M. K., Wilson, R. H., & North, K. (2005). Actn3 Genotype Is Not Associated With Elite Endurance Athlete Status In Ethiopians And Kenyans: 2469 3: 30 PM‐3: 45 PM. Medicine & Science in Sports & Exercise, 37(5), S472.
Fuente de los datos: Dialnet